A Study to Investigate Safety, Reactogenicity, and Immunogenicity of mRNA-1365 (Profile 2) in Older Healthy Adults

Clinical trial NCT07764237 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07764237
Sponsor: ModernaTX, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Respiratory Syncytial Virus (RSV)Human Metapneuomovirus (hMPV)

Start date: 2026-08-16
Primary completion: 2027-07-20
Enrollment: 375

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.